New NIOSH nod, 3M Aura 1870+ respirator tightens its grip on healthcare demand

3M’s Aura 1870+ NIOSH-approved N95 respirator targets hospitals and healthcare workers with a flat-fold design, 3-panel construction and high filtration efficiency for airborne particles, as infection-prevention budgets tighten and demand for reliable disposable masks stays elevated.

Edited by ad hoc news New Releases & Launches Desk. Reviewed before publication on 06/16/2026 at 9:30 AM ET. Details in the imprint.

The 3M Aura 1870+ N95 Health Care Particulate Respirator and Surgical Mask is one of 3M Company’s key offerings for hospitals and clinics, combining NIOSH-approved N95 respiratory protection with fluid resistance for use in operating rooms and high-risk patient care. The flat-fold, three-panel respirator is designed to fit a wide range of face shapes while maintaining a tight seal, a priority for healthcare systems that have spent the past years tightening fit-testing protocols and infection-prevention procedures. According to 3M, the Aura 1870+ is intended for both respiratory protection and as a surgical mask in environments where exposure to blood and bodily fluids is possible, positioning it as a workhorse mask for front-line staff.

What the 3M Aura 1870+ N95 respirator offers hospitals

At its core, the 3M Aura 1870+ is an N95 respirator that has been cleared by the U.S. Food and Drug Administration (FDA) as a surgical mask and certified by NIOSH as an N95 filtering facepiece respirator, meeting requirements for at least 95 percent filtration efficiency against non-oil-based airborne particles when properly fitted and used. The model features 3M’s three-panel Aura design, which allows the mask to flex and move with facial motion, helping maintain a seal while clinicians talk, turn their heads or perform procedures. 3M specifies that the product is intended for single-use, disposable applications and is not approved for use in atmospheres containing oil aerosols or for gases and vapors, which makes it a targeted solution for healthcare rather than industrial chemical environments. Hospitals typically deploy the Aura 1870+ in areas such as isolation rooms, emergency departments and intensive care units, where airborne pathogens like tuberculosis or emerging respiratory viruses are a concern and where staff must combine respiratory protection with fluid splash resistance. The respirator incorporates a foam nose pad and adjustable nose clip to reduce the potential for eyewear fogging and to improve comfort over extended shifts, a key factor in user compliance during long procedures. The mask is also designed without natural rubber latex, which helps institutions reduce the risk of allergic reactions among staff.

One of the notable design elements of the Aura 1870+ is its flat-fold, individually wrapped packaging, which allows facilities to store and distribute the masks more efficiently than traditional cup-shaped respirators while supporting point-of-use hygiene. Each mask is individually packaged to help protect it from contamination before use, a detail that appeals to infection-prevention teams focused on reducing cross-contamination from shared storage bins. The three-panel construction enables the lower panel to be pulled under the chin for more secure coverage, while the top panel is shaped to contour around the nose and across the cheeks, which can help with a broader range of face sizes during fit testing. Many hospital buyers also point to the mask’s relatively low breathing resistance as a differentiator; by optimizing the filter media and surface area, 3M seeks to balance protection with airflow to reduce fatigue for staff who may need to wear N95 protection for several hours at a time. Facilities comparing products often weigh this comfort factor against alternatives such as reusable elastomeric respirators or powered air-purifying respirators, which offer different cost and maintenance profiles but are less convenient for rapid deployment in large numbers.

Supply continuity remains a central consideration for hospital procurement teams, and 3M has emphasized that the Aura 1870+ sits within its broader portfolio of healthcare respirators and masks, which are manufactured across multiple sites and subject to quality and performance testing under international standards. During the acute phase of the COVID-19 pandemic, demand spikes and supply constraints pushed many institutions to diversify their N95 sources, but many have since consolidated back toward established brands as global supply chains stabilized. For 3M, the Aura 1870+ and related models function as an anchor line for recurring consumable revenue in its Health Care segment, even as the company executes its broader restructuring and portfolio adjustments in other business units. Some U.S. group purchasing organizations and large hospital systems include the Aura 1870+ on their standard N95 formulary, creating reasonably predictable volume, though actual purchase patterns depend on local infection rates, regulatory guidance and budget cycles. Infection-prevention specialists evaluating mask options generally consider filtration certification, fit-test pass rates, comfort feedback from staff and the ability to maintain stockpiles at target levels when determining which models to standardize on.

For 3M, which has been simplifying its corporate structure and addressing legacy liabilities, stable demand from healthcare PPE such as the Aura 1870+ provides a counterweight to more cyclical industrial businesses and consumer segments. Respiratory protection is not the company’s largest line by revenue, but it is strategically important given heightened attention to workplace safety and infection control in hospitals worldwide. Shares of 3M Company (US88579Y1010) traded on the NYSE at $104.32 on 06/13/2026.

3M Aura 1870+ N95 quick profile

• Product: 3M Aura 1870+ N95 Health Care Particulate Respirator and Surgical Mask
• Manufacturer: 3M Company
• Category: New Release / Launch - healthcare respirator
• Launch date: Original Aura 1870 series introduced in the 2010s; 1870+ is the updated variant currently marketed
• MSRP / Price: Typically sold via distributors and hospital supply contracts; unit pricing varies by volume and channel
• Availability: Widely available through medical supply distributors, hospital group purchasing organizations and select online channels
• Target audience: Hospitals, clinics, surgical centers and healthcare workers requiring NIOSH-approved N95 respiratory protection with fluid resistance
• Key differentiator / USP: Combination of NIOSH-approved N95 filtration, FDA-cleared surgical mask status and three-panel Aura design for comfort and fit

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.